Cite
High serum magnesium is associated with lower risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease.
MLA
Yu, Yi‐Chuan, et al. “High Serum Magnesium Is Associated with Lower Risk of Hepatocellular Carcinoma among Patients with Nonalcoholic Fatty Liver Disease.” Cancer (0008543X), vol. 129, no. 15, Aug. 2023, pp. 2341–47. EBSCOhost, https://doi.org/10.1002/cncr.34799.
APA
Yu, Y., Paragomi, P., Wang, R., Liang, F., Luu, H. N., Behari, J., & Yuan, J. (2023). High serum magnesium is associated with lower risk of hepatocellular carcinoma among patients with nonalcoholic fatty liver disease. Cancer (0008543X), 129(15), 2341–2347. https://doi.org/10.1002/cncr.34799
Chicago
Yu, Yi‐Chuan, Pedram Paragomi, Renwei Wang, Feiran Liang, Hung N. Luu, Jaideep Behari, and Jian‐Min Yuan. 2023. “High Serum Magnesium Is Associated with Lower Risk of Hepatocellular Carcinoma among Patients with Nonalcoholic Fatty Liver Disease.” Cancer (0008543X) 129 (15): 2341–47. doi:10.1002/cncr.34799.